Tuberculosis Therapy
Thalidomide analog adjunct effective against tuberculous meningitis
Published in TB and Outbreaks Week, July 30th, 2002
"Tuberculous meningitis (TBM), the most severe form of Mycobacterium tuberculosis infection in humans, is associated with significant morbidity and mortality despite successful treatment with antituberculous drugs," explained Liana Tsenova and colleagues working at The Rockefeller University in New York City and Celgene Corporation in Warren, New Jersey. "This is due to the irreversible brain damage subsequent to the local inflammatory response of the host to M....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Infectious Disease
Nipah virus infection can lead to recurrent encephalitis - Bacteriology
Fluid forces within the body help invasive bacteria - Infectious Disease Therapy
Colistin ineffective against drug-resistant Acinetobacter baumannii - Rocky Mountain Spotted Fever
When it comes to ticks, once bitten isn't always twice shy - Antibiotics
Antimicrobial resistance: Trying to outsmart a pandemic - Blood Supplies
Stricter donor guidelines may mean dramatically reduced blood supply - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
